Dynasil of America (Dynasil of America) Risk Assessment

View and export this data going back to 2000. Start your Free Trial

What is Dynasil of America Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Dynasil of America is: No Data: Cannot be evaluated.

Competitive Comparison of Dynasil of America's Risk Assessment

For the Scientific & Technical Instruments subindustry, Dynasil of America's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dynasil of America's Risk Assessment Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Dynasil of America's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Dynasil of America's Risk Assessment falls into.

Dynasil of America (OTCPK:DYSL) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Dynasil of America Risk Assessment Related Terms

Thank you for viewing the detailed overview of Dynasil of America's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Dynasil of America (Dynasil of America) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Dynasil Corp of America (OTCPK:DYSL) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

313 Washington Street, Suite 403, Newton, MA, USA, 02458

Website

https://www.dynasil.com

Dynasil Corp of America is a US-based company. It operates in three segments. The Optics segment, which is the key revenue driver, encompasses Dynasil Fused Silica, Evaporated Metal Films, Hilger Crystals, and Optometrics. It manufactures commercial products, including optical crystals for sensing in the security and medical imaging markets, and optical components, optical coatings and optical materials for scientific instrumentation and other applications. The Innovation and Development segment consists of the Radiation Monitoring Devices. The Biomedical segment consists of Dynasil Biomedical, a medical technology incubator that owns rights to certain early-stage medical technologies.

Executives

Bowdring Robert Joseph Jr	officer: Former CFO	92 GOULD STREET, WAKEFIELD MA 01880
Alan B Levine	director
Lawrence Joseph Fox	director	C/O ABERDEEN ASSET MANAGEMENT INC., 1735 MARKET STREET - 32ND FLOOR, PHILADELPHIA PA 19103
Craig T Dunham	director, 10 percent owner	DYNASIL CORPORATION, 385 COOPER ROAD, WEST BERLIN NJ 08091
David Kronfeld	director	JK&B CAPITAL, 180 N. STETSON AVENUE, SUITE 4500, CHICAGO IL 60601
Thomas C Leonard	director	KADANT INC., 1 TECHONOLOGY PARK DRIVE, WESTFORD MA 01886
Gerald Entine	10 percent owner	100 BELVIDERE STREET, SUITE 10B, BOSTON MA 02199